SRRA Sierra Oncology

Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.

$17.99
As of 06/24/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  
IPO date:  07/16/2015
Outstanding shares:  12,349,961
Average volume:  9,504
Market cap:   $212,419,329
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    82640U107
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -6.83
PB ratio:   0.57
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy